Cervical Cancer
Study Findings on Cervical Cancer Are Outlined in Reports from University of Copenhagen
Published in Vaccine Weekly, October 5th, 2011
2011 OCT 5 -- According to the authors of recent research from Hvidovre, Denmark, "Mass vaccination against human papillomavirus (HPV) genotypes 16 and 18 will, in the long term, reduce the incidence of cervical cancer, but screening will remain an important cancer control measure in both vaccinated and unvaccinated women. Since the 19605, cytology screening has helped to reduce the incidence of cervical cancer, but has a low sensitivity for high-grade cervical intraepithelial neoplasia (CIN) and requires frequent testing."
"Several HPV tests have become available commercially. They appear to be more sensitive for high-grade CIN, and may further reduce the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2011-10-05)
More Articles from Vaccine Weekly
- Pediatric Vaccines
Research from University of Medicine and Dentistry of New Jersey Provides New Data about Pediatric Vaccines - Vaccines
Studies from Federal University Have Provided New Data on Vaccines - Gene Therapy
Aduro BioTech, Inc. Appoints Thomas Dubensky, Jr. as Chief Scientific Officer - Vaccines
Brigham and Women's Hospital researcher receives NIH Transformative Research Project Award - Immunoglobulins
Data from Charite University Hospital and School of Medicine Advance Knowledge in Immunoglobulins - Vaccinia
Data from E. Yu and Colleagues Advance Knowledge in Vaccinia - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
